Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories (BIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,983,094
  • Shares Outstanding, K 29,844
  • Annual Sales, $ 2,546 M
  • Annual Income, $ 3,806 M
  • 60-Month Beta 0.81
  • Price/Sales 6.94
  • Price/Cash Flow 55.71
  • Price/Book 1.79
Trade BIO with:

Options Overview

Details
  • Implied Volatility 35.10%
  • Historical Volatility 24.44%
  • IV Percentile 48%
  • IV Rank 30.54%
  • IV High 52.73% on 04/15/20
  • IV Low 27.34% on 08/18/20
  • Put/Call Vol Ratio 2.39
  • Today's Volume 61
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 138
  • Open Int (30-Day) 145

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.50
  • Number of Estimates 1
  • High Estimate 2.50
  • Low Estimate 2.50
  • Prior Year 1.91
  • Growth Rate Est. (year over year) +30.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
547.22 +10.37%
on 03/25/21
606.27 -0.38%
on 04/12/21
+44.01 (+7.86%)
since 03/12/21
3-Month
545.00 +10.82%
on 01/27/21
689.00 -12.34%
on 02/12/21
-6.05 (-0.99%)
since 01/12/21
52-Week
390.93 +54.50%
on 04/13/20
689.00 -12.34%
on 02/12/21
+210.85 (+53.63%)
since 04/09/20

Most Recent Stories

More News
Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day

Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day

LOGI : 108.14 (-0.80%)
HOG : 41.95 (-0.24%)
BIO : 603.99 (+0.24%)
IDXX : 506.43 (+0.71%)
FLGT : 82.30 (-3.64%)
COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks

We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.

BDX : 247.41 (-0.21%)
DGX : 128.86 (+1.71%)
ABT : 121.04 (+0.12%)
BIO : 603.99 (+0.24%)
IDXX : 506.43 (+0.71%)
FLGT : 82.30 (-3.64%)
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down

Walgreens Boots' (WBA) fiscal second-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.

ALGN : 601.11 (+1.44%)
BIO : 603.99 (+0.24%)
IDXX : 506.43 (+0.71%)
WBA : 54.70 (+0.96%)
The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Cardinal Health, Abbott Lab, Hologic and Bio-Rad Lab

BDX : 247.41 (-0.21%)
CAH : 60.86 (+1.35%)
HOLX : 74.42 (+1.07%)
ABT : 121.04 (+0.12%)
BIO : 603.99 (+0.24%)
CVS Health (CVS) Extends COVID-19 Testing in Massachusetts

CVS Heath's (CVS) antibody testing to be available in nearly 60 MinuteClinic locations and cost $38.

CVS : 74.46 (+0.53%)
ABT : 121.04 (+0.12%)
HRC : 112.02 (-0.81%)
BIO : 603.99 (+0.24%)
Here's Why You Should Add Bio-Rad (BIO) to Your Portfolio

Investors remain optimistic about Bio-Rad (BIO) backed by strong segmental performance across geographies and robust testing portfolio.

OMI : 36.76 (+0.16%)
VIVO : 24.02 (-4.07%)
BIO : 603.99 (+0.24%)
NVST : 41.76 (-1.23%)
Why Is Bio-Rad (BIO) Down 13% Since Last Earnings Report?

Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BIO : 603.99 (+0.24%)
Bio-Rad to Participate in Barclays Global Healthcare Conference 2021

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive...

BIO : 603.99 (+0.24%)
Bio-Rad to Participate in Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO; Andrew Last, Executive...

BIO : 603.99 (+0.24%)
What Makes Bio-Rad Laboratories (BIO) a Strong Momentum Stock: Buy Now?

Does Bio-Rad Laboratories (BIO) have what it takes to be a top stock pick for momentum investors? Let's find out.

BIO : 603.99 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials,...

See More

Key Turning Points

3rd Resistance Point 614.42
2nd Resistance Point 610.34
1st Resistance Point 607.17
Last Price 603.99
1st Support Level 599.92
2nd Support Level 595.84
3rd Support Level 592.67

See More

52-Week High 689.00
Last Price 603.99
Fibonacci 61.8% 575.14
Fibonacci 50% 539.96
Fibonacci 38.2% 504.79
52-Week Low 390.93

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar